SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Transcript of Conference Call with Investors/Analysts

pdf

Piramal Pharma Ltd.

26 May 2023

182.05

-1.74%

Piramal Pharma Results Earnings Call for Q4FY23

Conference Call with Piramal Pharma Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

Piramal Pharma Ltd.

18 May 2023

182.05

-1.74%

Earnings Call

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Intimation of Conference Call with Investors/Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 ('Listing Regulations')

pdf

Piramal Pharma Ltd.

13 Feb 2023

182.05

-1.74%

Earnings Call

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Conference Call with Investors/Analysts

pdf

Piramal Pharma Ltd.

09 Feb 2023

182.05

-1.74%

Earnings Call

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2022

pdf

Piramal Pharma Ltd.

11 Nov 2022

182.05

-1.74%

Earnings Call

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Transcript of Conference Call with Investors/Analysts

pdf

Piramal Pharma Ltd. Conference Calls and Earnings Call Transcripts

Piramal Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Earnings Calls Podcast on